Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis
Primary Purpose
Multiple Sclerosis
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Lung volume recruitment
Sponsored by
About this trial
This is an interventional prevention trial for Multiple Sclerosis focused on measuring Multiple sclerosis, Lung volume recruitment, Pulmonary function impairment, Cough impairment
Eligibility Criteria
Inclusion Criteria:
- History of multiple sclerosis, diagnosed by a neurologist in accordance with the 2010 McDonald criteria
Exclusion Criteria:
- Concomitant parenchymal pulmonary disease or pleural disease
- Symptomatic cardiomyopathy
- Unable to perform pulmonary function testing or lung volume recruitment, due to comprehension or cooperation issues, physical inability such as bulbar or cerebellar dysfunction
- Contra-indication to pulmonary function testing or lung volume recruitment such as myocardial infarction, bleeding aortic aneurysm, intracranial hemorrhage within the previous month
- Known susceptibility to pneumothorax or pneumomediastinum
- Not competent to provide informed consent
Sites / Locations
- The Ottawa HospitalRecruiting
- Hôpital Charles-LeMoyneRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Lung volume recruitment
Standard care
Arm Description
Lung volume recruitment twice daily for 9 months
Standard care
Outcomes
Primary Outcome Measures
Rate of decline of FVC (forced vital capacity)
Secondary Outcome Measures
Rate of decline of peak cough flow
Change from baseline in FVC at 2, 4, 6 and 9 months
Change from baseline in peak cough flow at 2, 4, 6 and 9 months
Full Information
NCT ID
NCT01891071
First Posted
February 25, 2013
Last Updated
March 29, 2016
Sponsor
Ottawa Hospital Research Institute
Collaborators
The Ottawa Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01891071
Brief Title
Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis
Official Title
Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Unknown status
Study Start Date
July 2013 (undefined)
Primary Completion Date
April 2017 (Anticipated)
Study Completion Date
April 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ottawa Hospital Research Institute
Collaborators
The Ottawa Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Multiple sclerosis is a neurological disease that can affect lung function and cough efficacy. This pilot study will examine whether the lung volume recruitment technique can slow down the decline in lung function and cough.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Multiple sclerosis, Lung volume recruitment, Pulmonary function impairment, Cough impairment
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
35 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Lung volume recruitment
Arm Type
Experimental
Arm Description
Lung volume recruitment twice daily for 9 months
Arm Title
Standard care
Arm Type
No Intervention
Arm Description
Standard care
Intervention Type
Procedure
Intervention Name(s)
Lung volume recruitment
Other Intervention Name(s)
Air stacking, Glossophayngeal breathing
Intervention Description
Inflation of the lungs to their maximal insufflation capacity by the consecutive delivery, by a manual resuscitator in this study, of volumes of air that are held with a closed glottis
Primary Outcome Measure Information:
Title
Rate of decline of FVC (forced vital capacity)
Time Frame
up to 9 months
Secondary Outcome Measure Information:
Title
Rate of decline of peak cough flow
Time Frame
baseline, 2, 4, 6 and 9 months
Title
Change from baseline in FVC at 2, 4, 6 and 9 months
Time Frame
baseline vs 2, 4, 6 and 9 months
Title
Change from baseline in peak cough flow at 2, 4, 6 and 9 months
Time Frame
baseline vs 2, 4, 6 and 9 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
History of multiple sclerosis, diagnosed by a neurologist in accordance with the 2010 McDonald criteria
Exclusion Criteria:
Concomitant parenchymal pulmonary disease or pleural disease
Symptomatic cardiomyopathy
Unable to perform pulmonary function testing or lung volume recruitment, due to comprehension or cooperation issues, physical inability such as bulbar or cerebellar dysfunction
Contra-indication to pulmonary function testing or lung volume recruitment such as myocardial infarction, bleeding aortic aneurysm, intracranial hemorrhage within the previous month
Known susceptibility to pneumothorax or pneumomediastinum
Not competent to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nadim Srour, MD, MSc
Organizational Affiliation
Université de Sherbrooke
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Douglas A McKim, MD
Organizational Affiliation
The Ottawa Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Ottawa Hospital
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1H 8L6
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Doug A. McKim, MD
Phone
613-737-8899
Ext
16448
Email
dmckim@ottawahospital.on.ca
First Name & Middle Initial & Last Name & Degree
Doug A McKim, MD
Facility Name
Hôpital Charles-LeMoyne
City
Greenfield Park
State/Province
Quebec
ZIP/Postal Code
J4V2H1
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nadim Srour, MD
Phone
450-466-5000
Ext
2734
Email
nadim.srour@usherbrooke.ca
First Name & Middle Initial & Last Name & Degree
Nadim Srour, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
23383293
Citation
Srour N, LeBlanc C, King J, McKim DA. Lung volume recruitment in multiple sclerosis. PLoS One. 2013;8(1):e56676. doi: 10.1371/journal.pone.0056676. Epub 2013 Jan 31.
Results Reference
background
Learn more about this trial
Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis
We'll reach out to this number within 24 hrs